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There is still disagreement as to the value and reliability of wash and brush cytology, in comparison with histology,
for the diagnosis of malignancy at flexible bronchoscopy. The present study compares the yield and concordance of
findings from the two modalities for visible tumours at flexible bronchoscopy.
A single-centre study of 514 consecutive flexible bronchoscopy procedures, in which a lesion suspicious of cancer
was seen and bronchial wash cytology, brush cytology and forceps biopsy samples were taken. All equivocal or
suspicious results were taken as negative.
An overall yield of 89?3% was achieved using a combination of all three tests. This was greater for endobronchial
than submucosal (95% vs. 86%) tumours. Cytology alone diagnosed 17?7% of cases. Use of all three modalities
allowed tumours to be differentiated between small and non-small cell types in all but 5/459 positive cases (98?9%).
There were only 3/313 cases in which there was a difference in cell type (small cell vs. non-small cell) between the
two modalities.
We conclude that wash and brush cytology are valuable tools, in addition to forceps biopsy, at flexible
bronchoscopy. All three tests should be performed routinely in cases of suspected malignancy.
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Lung cancer has become the most common fatal malig-
nancy in adults in the United Kingdom, with about 35 000
new cases per year (1). The British Thoracic Society
guidelines for the care of patients with lung cancer state
that histological or cytological confirmation should be
sought in all cases unless a respiratory physician or other
specialist has given an explicit opinion that this would be
inappropriate (2). Histological or cytological confirmation
is known to be associated with a higher rate of specific
oncology treatment for lung cancer patients (3). The most
commonly used procedure for establishing the diagnosis is
flexible bronchoscopy. It is important that the maximum
amount of diagnostic information is obtained at every
bronchoscopy procedure, as if the test is negative the
patient will usually require further investigations, incurring
time delays and possible discomfort. Some authors suggestReceived 26 October 2000 and accepted in revised form 29 January
2001.
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0954-6111/01/050374+05 $35?00/0cytology does not add to the diagnostic yield from biopsy
for endobronchial tumours (4), whilst others consider the
two modalities as complementary (5,6).
This study examined the yield from cytology and
histology in cases where a suspected endobronchial
(exophytic) or submucosal (intra-mural or ulcerative) lesion
was seen at flexible bronchoscopy. The results from the two
modalities were directly compared. For those cases with
negative or discrepant results, the patient’s case notes were
retrieved to try to establish the eventual outcome.
Materials and methods
Hope Hospital is a 1000-bed teaching hospital in inner-city
Salford. This area has one of the highest standardized
mortality ratios (SMR) for lung cancer in the U. K. (SMR
160—Salford and Trafford Health Authority 1994–1996
data). The Respiratory Unit at Hope Hospital performs
approximately 400 flexible bronchoscopy procedures each
year. The majority are undertaken in the investigation of a
suspected underlying lung cancer (64%) or haemoptysis
(14%). The records of all flexible bronchoscopy procedures
performed in the respiratory unit from 1992 onwards are
recorded in a computerized database.# 2001 HARCOURT PUBLISHERS LTD
FIG. 1 Percentage diagnostic yield for bronchial washing,
brushing and forceps biopsies when a suspected tumour
was seen at flexible bronchscopy (n=514).
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to have a submucosal or endobronchial lesion suspicious of
cancer. We described fungating or exophytic tumours as
‘endobronchial’ and we described intra-mural or ulcerative
lesions as ‘submucosal’. We did not include cases with
normal mucosa but apparent narrowing of airways due to
extrinsic or extra-mural compression. We studied only
those cases in which sampling with wash cytology, brush
cytology and forceps biopsy had all been performed. All
bronchoscopies were carried out by one of six experienced
operators. The endoscopies were performed transnasally
under local anaesthesia. The sequence of sampling was as
follows.
BRUSHING
Brushings were taken using ‘microvasive ME1600 BT/1-0/
58/140’ sheathed disposable cytology brushes (Boston
Scientific Limited, St Albans, U.K.). After each brushing
the brush is sheathed then withdrawn from the broncho-
scope. Brushings are smeared onto a glass slide using a
circular motion. The slides are then immediately immersed
into 95% alcohol solution. This procedure is then repeated
as we aim to take two separate brush specimens from each
lesion. This system is used in order to minimize the number
of cases in which the brush samples are inadequate for
cytological interpretation, usually because of air-drying
artifact. The smears are routinely stained by haematoxylin
and eosin (H&E) and Papanicolaou methods.
FORCEPS BIOPSY
We aim to take five bronchial biopsies from each lesion
using a standard cup forceps, unless limited by patient
tolerability of procedure or complications, such as bleeding.
Biopsy samples are immediately fixed in 10% formalin
solution and routinely processed for histology.
WASHING
Washings are obtained by lavage with 10–40ml of 0?9%
saline. This is aspirated and collected into a trap. It is
transported to the laboratory and centrifuged. Direct
smears are made from the sediment and staining is by the
H&E and Papanicolaou methods.
Pathology specimens are reported by one of three
experienced histopathologists, with assistance from junior
pathologists. Policy in our unit is to identify small cell lung
cancer as distinct from non-small cell lung cancer.
The original cytology and histology material was re-
examined in each case. For the purpose of this study,
specimens are considered as small cell lung cancer, non-
small cell lung cancer (NSCLC) (when further subclassifi-
cation is not possible on the size of sample available),
squamous cell lung cancer, adenocarcinoma, lymphoma
and non-specific undifferentiated lung carcinoma. The
specimens of cases that had positive results for both
cytology (brush and/or wash) and histology were compared
to establish if there were discrepancies in findings betweenthe two modalities. The case records of patients with
negative results were reviewed to assess the subsequent
clinical outcome.
Although ‘suspicious’ or ‘atypical’ results are clinically
important and should lead to further investigations, as
malignancy may be present, they do not confirm cancer or
indicate tumour cell type; therefore for the purpose of this
study we have treated all suspicious/atypical results as
negative.
Results
A total of 1852 flexible bronchoscopy procedures were
performed in our unit from October 1991 to February 1997,
the vast majority (78%) in the investigation of a suspected
tumour or haemoptysis. A suspected endobronchial or
submucosal tumour was seen in 593 cases (47% ‘endo-
bronchial lesion’ intruding into the lumen of the airway,
53% ‘submucosal lesion’ or ulcerative lesion in the wall of
the airway). In 514 cases the lesion was sampled using all
three techniques of bronchial wash cytology, brush
cytology and forceps biopsy. These cases were used as our
study group.
The percentage diagnostic yield for bronchial washings,
brushings and biopsies are shown in Fig. 1. Use of the
376 A. M. JONES ET AL.combination of all three techniques produced an overall
yield of 89?3%. This figure was higher for endobronchial
(95%) than submucosal (86%) tumours. The overall
positive yield for each technique was brushings, 369
patients (71?8%), biopsies, 368 patients (71?6%) and
washings, 232 patients. The wash samples were not
screened in 31 cases as during recent years our practice
has been to take washings but, in order to ensure our
practice is cost-effective, they are examined by the
cytologist only if the brushings and biopsies are both
negative. The total positive yield for wash cytology,
excluding the cases not screened, was 48%. There was
no significant difference in yield between any of the
operators.
A significant number of patients (17?7%) had a negative
histology but positive cytology result. Brush cytology was
more likely to be positive than wash cytology (15?6% vs.
9?7%) in cases with a negative biopsy result.
There were 55 cases (10?7%) in which the operator
reported a visible lesion suspicious of an endobronchial or
submucosal tumour, but the samples taken were not
diagnostic of malignancy. In 10 cases, the pathologist
reported samples as being ‘suspicious’ or ‘highly suspicious’
of malignancy. A firm diagnosis of cancer was eventually
achieved in 21 cases. This was achieved by a repeat flexible
bronchoscopy in three cases, rigid bronchoscopy in seven
cases (there were a further five cases in which all specimens
from rigid bronchoscopy were also negative) and by the use
of a different procedure, such as surgical resection, in 11
cases. Four were found to have unusual lung tumours (one
case of carcinosarcoma, one atypical carcinoid and two
lymphomas). Two other patients had primary renal
carcinomas with pulmonary metastatic disease. Review of
the case-notes revealed that a further 28 patients had a
subsequent clinical course consistent with an underlying
malignancy. Only four cases were thought to be ‘true
negatives’, two of which were found to have endobronchial
tuberculosis. No conclusion could be reached in two cases
as the case notes for one patient could not be traced and
another died of a gastrointestinal haemorrhage before it
could be satisfactorily concluded that the clinical course
was in keeping with an underlying cancer (a post-mortem
examination was not performed).
Tumours in this study were diagnosed as squamous cell
lung cancer (42?3% of cases), NSCLC (30?7%), small cell
lung cancer (21?4%), adenocarcinoma (3?7%), lymphoma
(0?2%), mixed cell types (0?6%) and non-specific undiffer-
entiated cancer (1?1%). Use of all three tests allowed
tumours to be differentiated between small and non-small
cell types in all but five out of 459 cases (98?9%), although
this was more likely to be possible from biopsy than
cytology specimens (98?9% vs. 94%). Two of the five cases
whose specimens were initially reported as showing tumour
cells of non-specific differentiation had been discussed by
the clinician with the pathologist. Upon review of the
original material and with the use of immunocytochemistry
techniques, it had been thought there were enough features
to allow a differentiation between small cell and non-small
cell cancer to be made and the patients were referred for
treatment.There were three cases of mixed tumours on histology
(one small cell/NSCLC carcinoma, one adenosquamous
carcinoma and one squamous/small cell cancer).
There were three cases in which there was a discrepancy
between histology and cytology in the diagnosis of small
versus non-small cell lung cancer. In one of these cases the
discrepancy was resolved on review of the original H&E
sections. Of the remaining two cases, both were thought on
the initial report of the histology specimen to show a poorly
differentiated squamous cell carcinoma. The cytology
specimens were reported to contain small cell carcinoma
cells. Further immunocytochemical tests using synaptophy-
sin (DAKO, Ely, Cambridgeshire, U.K.) and cytokeratin
MNF116 (DAKO) and CAM5?2 (Becton Dickinson, San
Jose, California, U.S.A.) stains, were more suggestive of
small cell than non-small cell lung cancer, in keeping with
the original cytology results.
Discussion
We report a single centre study of 514 sequential flexible
bronchoscopy procedures, where a lesion suspicious of
cancer was seen and wash cytology, brush cytology and
forceps biopsy samples were all taken. In addition to
assessing the yield from cytology and histology, the present
study has also tried to address the concordance of findings
from the two modalities.
A diagnosis was achieved from a biopsy in 71?6% of
cases. The use of brush and wash cytology however,
allowed a further increase in diagnostic yield by 17?7%.
Previous studies have also demonstrated that use of
cytology increases the diagnostic yield at flexible broncho-
scopy for central tumours by between 4?5% to 23% (7–11).
An overall yield of 89?3% was achieved using all three tests
in our present study, although this was higher for
endobronchial (95%) than submucosal (86%) tumours.
The other studies had similar results for overall yield (7–
11), although the definition of a ‘visible tumour’ varied
between studies. Lam et al. (9) included only proven cases
of bronchial carcinoma. We studied all cases where a lesion
was seen. If we had excluded true negative cases and
patients who were deemed unfit for or refused further tests
(and therefore never proven histologically to have malig-
nancy), our overall yield would have risen to 95?6%.
The use of brush cytology allows the greater increase in
yield in addition to forceps biopsy (15?6%). A small but
significant percentage of patients are diagnosed by wash
cytology alone (2?1%). Govert et al. (7) showed that the
collection of routine cytological specimens at flexible
bronchoscopy could be cost-effective. In order to ensure
our practice remains cost-effective, our current policy is to
take wash cytology samples but these are only screened by
the cytologist if the forceps biopsy and brush cytology
specimens are negative. Other authors have examined yield
from different cytological techniques at flexible broncho-
scopy (12–14); our chosen combination of forceps biopsy,
brush cytology and wash cytology produces a high yield
and therefore we do not use other cytological techniques on
a routine basis.
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tumours at flexible bronchoscopy per year. If the results of
samples taken are negative, the patient usually will require
further investigation which may involve time delays and
discomfort. Furthermore, studies on patients’ attitudes to
bronchoscopy have shown that many would not be
prepared to have the procedure repeated (10). For our
own unit, we calculate the use of cytology can prevent the
need for a repeat procedure for approximately 19 patients
each year.
Small cell lung cancer has a distinctly different prognosis
and treatment protocol to the other cell types (5). Although
histology was more likely to give a greater degree of
differentiation of tumour cell type, most cytology-positive
cases could be identified as either small or non-small cell
lung cancer. The apparent low prevalence of adenocarci-
noma in the current series is probably due to the restriction
to central lung tumours and the use of very strict diagnostic
criteria by our pathologists. The use of a combination of all
three tests allowed tumours to be differentiated between
small and non-small cell cancers in all but five cases. Of the
five cases whose specimens were initially reported as
showing tumour cells of non-specific differentiation, two
were referred by the clinician for treatment without any
further invasive tests following discussion with the pathol-
ogist. In both cases the pathologist thought that, upon
review of the original material and with the subsequent
benefit of immunocytochemical staining, there were enough
features to allow a differentiation between small and non-
small cell cancer to be made. One other case was reported
by the histopathologist as ‘undifferentiated carcinoma cells,
probably metastatic’. The patient had known primary
breast cancer and the clinicians presumed the lung lesions
were endobronchial metastases. There were only two cases
in which it was thought that there was proof of malignancy
but no indication whether the tumour was of small or non-
small cell aetiology.
It is recognized that although tumour heterogeneity can
occur, a small cell carcinoma generally shows its character-
istic histological features throughout (5). For treatment
purposes it is important to separate small cell lung cancers
from non-small cell types. In the present study there were
only three cases in which a difference in cell type (small and
non-small cell carcinoma) occurred between the two
modalities. On review of all three cases, a final unifying
diagnosis (small vs. non-small cell) was made from the
original material. In two cases immunocytochemistry
supported the cytology diagnosis. Both above cases were
referred for chemotherapy and therefore resection
specimens were not available to give a definite answer for
the purpose of this study. Lamb and Corrin (5) have
challenged the common assumption that when comparing
histology and cytology the final histological diagnosis is
always correct, suggesting that in some cases cytological
features, as opposed to tissue patterns, might be of more
value (5). The findings of the present study provide support
for Lamb’s suggestion. Accuracy from forceps biopsy
samples may not be superior to cytology for central
tumours. The gold standard remains the resection
specimen.We believe our data provides for the establishment of
minimal standards for overall yield from flexible broncho-
scopy. We believe that regular feedback and audit between
bronchoscopy and histocytology staff contribute to the high
standard of practice in our unit. In the present study use of
bronchial washing, bronchial brushing and forceps biopsy
enabled an overall yield of 95% to be achieved for
endobronchial tumours. The recent Scottish multi-centre
study has shown that the overall yield for frank tumour
varies between Scottish bronchoscopy units (80–95%) and
that those centres using greater number of sampling
techniques have higher yields (10). It is known that the
maximal diagnostic yield from a visible tumour using
bronchial biopsy is only achieved after at least four to five
samples have been taken (11,15). At each procedure we
attempted to take at least five forceps biopsy samples,
unless limited by others factors such as troublesome
bleeding. Yield has also been shown to increase with
multiple brushings (116). We take two brush samples from
each lesion. In the present study there was no significant
difference in overall yield between operators, irrespective of
seniority of staff. This is in keeping with similar findings by
McLean et al. (10). In our series, the number of samples
taken which were deemed unsuitable for diagnostic
purposes by the histopathologists was very low (51%).
The potential value of continued audit to achieve best
results has also been highlighted by other authors (10).
For treatment purposes the most important information
required from flexible bronchoscopy is the confirmation of
malignancy, staging of the tumour and the differentiation
between small cell and non-small cell cancer. Our data
shows that use of brush and wash cytology allows these
criteria to be met in a significantly greater number of cases
than would be achieved by use of biopsy alone. Further-
more our data indicates that at bronchoscopy, cytology
may be as reliable as bronchial biopsy in distinguishing
between small cell and non-small cell tumours. Use of brush
and wash cytology ensures that the maximal amount of
diagnostic information is achieved at flexible bronchoscopy
when a lesion suspicious of malignancy is seen.
Summary points
(1) When an experienced operator reports a suspected
submucosal or endobronchial tumour at flexible broncho-
scopy, use of all three sampling techniques (wash cytology/
brush cytology/biopsy histology) will enable a rapid
confirmation of diagnosis in the majority (89?3%) of cases.
(2) When a visible lesion is sampled by bronchial biopsy
supplemented by brush and wash cytology, a significant
proportion (17?7%) of cases may be diagnosed exclusively
by cytology.
(3) Histology specimens are more likely to allow a greater
degree of tumour cell type differentiation than cytology, but
use of a combination of wash cytology, brush cytology and
forceps biopsy will distinguish between NSCLS and small
cell cancer in the majority of cases (98?9%).
(4) Concordance between bronchial biopsy histology and
cytology (brush and wash) results is high (499%).
378 A. M. JONES ET AL.(5) Most positive cases are diagnosed from either brush
cytology and/or biopsy, although wash cytology is still
valuable, as it alone will provide the diagnosis in 2?1% of
patients. It may be reasonable practice to screen the wash
specimen only if both the brushings and biopsies are
negative.
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